# Quoin Pharmaceuticals, Ltd.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/quoin-pharmaceuticals-ltd |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 22 |
| Claims under review | 1 |
| Evidence records | 5 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-21T04:48:59.447603+00:00 |
| Last reviewed | 2026-10-21T04:48:59.447603+00:00 |

## Identity

- Legal name: Quoin Pharmaceuticals, Ltd.
- Display name: Quoin Pharmaceuticals, Ltd.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-21T22:35:49.552296+00:00 |
| Completeness | 0.409 |
| Record Quality | 0.831 |
| Directors | 6 |
| Committees | 6 |
| Governance events | 13 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- Denise Carter: Director. Status: current. Independent: false. Since: 2021-01-01. claim_id=alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:5
- James Culverwell: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Audit (chair); Audit · Chair; Compensation (member); Compensation (member). claim_id=alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:6
- Joseph Cooper: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Audit (member); Audit; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:7
- Michael Sember: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:8
- Natalie Leong: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Audit (member); Audit; Nominating and Governance · Chair (member); Nominating and Governance (chair). claim_id=alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:9
- Dr. Dennis H. Langer: Director (committee appointment). Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. Committees: Compensation (chair). claim_id=alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:committee_record:16

## Committees

- Audit (audit). Chair: James Culverwell. Members: James Culverwell (chair, current); Joseph Cooper (member, current); Natalie Leong (member, current). committee_id=alpha:committee:quoin-pharmaceuticals-ltd:audit
- Audit · Chair; Compensation (audit). Chair: NOT_PUBLISHED. Members: James Culverwell (member, current). committee_id=alpha:committee:quoin-pharmaceuticals-ltd:audit-chair-compensation
- Audit; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Joseph Cooper (member, current). committee_id=alpha:committee:quoin-pharmaceuticals-ltd:audit-nominating-and-governance
- Audit; Nominating and Governance · Chair (audit). Chair: NOT_PUBLISHED. Members: Natalie Leong (member, current). committee_id=alpha:committee:quoin-pharmaceuticals-ltd:audit-nominating-and-governance-chair
- Compensation (compensation). Chair: Dr. Dennis H. Langer. Members: Dr. Dennis H. Langer (chair, current); James Culverwell (member, current); Michael Sember (member, current). committee_id=alpha:committee:quoin-pharmaceuticals-ltd:compensation
- Nominating and Governance (nominating_governance). Chair: Natalie Leong. Members: Natalie Leong (chair, current); Joseph Cooper (member, current). committee_id=alpha:committee:quoin-pharmaceuticals-ltd:nominating-and-governance

## Executive leadership

- Denise Carter: Chief Operating Officer and Director [COO]. Status: current. claim_id=alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:10
- Sally Lawlor: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:11

## Governance events

- EXECUTIVE_APPOINTED: Denise Carter executive of Quoin Pharmaceuticals, Ltd., effective 2026-03-26. Effective: 2026-03-26. Detected: 2026-10-21T04:48:59.447603+00:00. event_id=alpha:event:transition:bs59hh1rciym5
- CFO_CHANGED: Sally Lawlor executive of Quoin Pharmaceuticals, Ltd., effective 2026-03-26. Effective: 2026-03-26. Detected: 2026-10-21T04:48:59.447603+00:00. event_id=alpha:event:transition:pildxtknj8wf
- DIRECTOR_APPOINTED: Denise Carter seat on Quoin Pharmaceuticals, Ltd., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-21T04:48:59.447603+00:00. event_id=alpha:event:transition:o7yadb1x1ptuh
- DIRECTOR_APPOINTED: James Culverwell seat on Quoin Pharmaceuticals, Ltd., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-21T04:48:59.447603+00:00. event_id=alpha:event:transition:hz3ouyhznyg6
- DIRECTOR_APPOINTED: Joseph Cooper seat on Quoin Pharmaceuticals, Ltd., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-21T04:48:59.447603+00:00. event_id=alpha:event:transition:q2xjtlghje4z
- DIRECTOR_APPOINTED: Michael Sember seat on Quoin Pharmaceuticals, Ltd., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-21T04:48:59.447603+00:00. event_id=alpha:event:transition:1kjas1k1bmrxm0
- DIRECTOR_APPOINTED: Natalie Leong seat on Quoin Pharmaceuticals, Ltd., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-21T04:48:59.447603+00:00. event_id=alpha:event:transition:x4demv1buapbx
- COMMITTEE_CREATED: Audit · Chair; Compensation committee of Quoin Pharmaceuticals, Ltd., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-21T04:48:59.447603+00:00. event_id=alpha:event:transition:1f4str63f228e
- COMMITTEE_MEMBER_ADDED: James Culverwell member of Audit · Chair; Compensation, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-21T04:48:59.447603+00:00. event_id=alpha:event:transition:1x3gc7oz3zg58
- COMMITTEE_CREATED: Audit; Nominating and Governance committee of Quoin Pharmaceuticals, Ltd., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-21T04:48:59.447603+00:00. event_id=alpha:event:transition:11ojlx7vmkvn
- COMMITTEE_MEMBER_ADDED: Joseph Cooper member of Audit; Nominating and Governance, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-21T04:48:59.447603+00:00. event_id=alpha:event:transition:15gn1ycuhfg96
- COMMITTEE_CREATED: Audit; Nominating and Governance · Chair committee of Quoin Pharmaceuticals, Ltd., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-21T04:48:59.447603+00:00. event_id=alpha:event:transition:3xub871npn2sl
- COMMITTEE_MEMBER_ADDED: Natalie Leong member of Audit; Nominating and Governance · Chair, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-21T04:48:59.447603+00:00. event_id=alpha:event:transition:1kbqyae1ny1bgw

## Scoped resources

- `alpha://company/quoin-pharmaceuticals-ltd` (contract): https://registry.alpha.ac/api/public/companies/quoin-pharmaceuticals-ltd?format=record
- `alpha://company/quoin-pharmaceuticals-ltd/identity` (contract): https://registry.alpha.ac/api/public/companies/quoin-pharmaceuticals-ltd?format=record&section=identity
- `alpha://company/quoin-pharmaceuticals-ltd/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/quoin-pharmaceuticals-ltd?format=record&section=corporate-structure
- `alpha://company/quoin-pharmaceuticals-ltd/board` (contract): https://registry.alpha.ac/api/public/companies/quoin-pharmaceuticals-ltd?format=record&section=board
- `alpha://company/quoin-pharmaceuticals-ltd/committees` (contract): https://registry.alpha.ac/api/public/companies/quoin-pharmaceuticals-ltd?format=record&section=committees
- `alpha://company/quoin-pharmaceuticals-ltd/leadership` (contract): https://registry.alpha.ac/api/public/companies/quoin-pharmaceuticals-ltd?format=record&section=leadership
- `alpha://company/quoin-pharmaceuticals-ltd/ownership` (contract): https://registry.alpha.ac/api/public/companies/quoin-pharmaceuticals-ltd?format=record&section=ownership
- `alpha://company/quoin-pharmaceuticals-ltd/financials` (contract): https://registry.alpha.ac/api/public/companies/quoin-pharmaceuticals-ltd?format=record&section=financials
- `alpha://company/quoin-pharmaceuticals-ltd/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/quoin-pharmaceuticals-ltd?format=record&section=capital-structure
- `alpha://company/quoin-pharmaceuticals-ltd/compensation` (contract): https://registry.alpha.ac/api/public/companies/quoin-pharmaceuticals-ltd?format=record&section=compensation
- `alpha://company/quoin-pharmaceuticals-ltd/governance` (contract): https://registry.alpha.ac/api/public/companies/quoin-pharmaceuticals-ltd?format=record&section=governance
- `alpha://company/quoin-pharmaceuticals-ltd/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/quoin-pharmaceuticals-ltd?format=record&section=shareholder-governance
- `alpha://company/quoin-pharmaceuticals-ltd/audit` (contract): https://registry.alpha.ac/api/public/companies/quoin-pharmaceuticals-ltd?format=record&section=audit
- `alpha://company/quoin-pharmaceuticals-ltd/legal` (contract): https://registry.alpha.ac/api/public/companies/quoin-pharmaceuticals-ltd?format=record&section=legal
- `alpha://company/quoin-pharmaceuticals-ltd/risk` (contract): https://registry.alpha.ac/api/public/companies/quoin-pharmaceuticals-ltd?format=record&section=risk
- `alpha://company/quoin-pharmaceuticals-ltd/cyber` (contract): https://registry.alpha.ac/api/public/companies/quoin-pharmaceuticals-ltd?format=record&section=cyber
- `alpha://company/quoin-pharmaceuticals-ltd/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/quoin-pharmaceuticals-ltd?format=record&section=ai-governance
- `alpha://company/quoin-pharmaceuticals-ltd/agents` (contract): https://registry.alpha.ac/api/public/companies/quoin-pharmaceuticals-ltd?format=record&section=agents
- `alpha://company/quoin-pharmaceuticals-ltd/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/quoin-pharmaceuticals-ltd?format=record&section=ecosystem
- `alpha://company/quoin-pharmaceuticals-ltd/events` (contract): https://registry.alpha.ac/api/public/companies/quoin-pharmaceuticals-ltd?format=record&section=events
- `alpha://company/quoin-pharmaceuticals-ltd/relationships` (contract): https://registry.alpha.ac/api/public/companies/quoin-pharmaceuticals-ltd?format=record&section=relationships
- `alpha://company/quoin-pharmaceuticals-ltd/assessments` (contract): https://registry.alpha.ac/api/public/companies/quoin-pharmaceuticals-ltd?format=record&section=assessments
- `alpha://company/quoin-pharmaceuticals-ltd/evidence` (contract): https://registry.alpha.ac/api/public/companies/quoin-pharmaceuticals-ltd?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- Claim alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:committee_appointment:13: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:james-culverwell","name":"James Culverwell"},"source_id":"board_seats"}`
- Claim alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:committee_appointment:14: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:joseph-cooper","name":"Joseph Cooper"},"source_id":"board_seats"}`
- Claim alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:natalie-leong","name":"Natalie Leong"},"source_id":"board_seats"}`
- Claim alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:dr-dennis-h-langer","name":"Dr. Dennis H. Langer"},"source_id":"board_seats"}`
- Claim alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:james-culverwell","name":"James Culverwell"},"source_id":"board_seats"}`
- Claim alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:michael-sember","name":"Michael Sember"},"source_id":"board_seats"}`
- Claim alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:natalie-leong","name":"Natalie Leong"},"source_id":"board_seats"}`
- Claim alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:joseph-cooper","name":"Joseph Cooper"},"source_id":"board_seats"}`

## Leadership

- Denise Carter: Director. Claim: alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:5. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9b21d6bc5d23b6d88be83349bf0b296bd63281ec25cdd55e97f7518c9df9f8a9.
- James Culverwell: Director, Audit · Chair; Compensation. Claim: alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:6. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9b21d6bc5d23b6d88be83349bf0b296bd63281ec25cdd55e97f7518c9df9f8a9.
- Joseph Cooper: Director, Audit; Nominating and Governance. Claim: alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:7. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9b21d6bc5d23b6d88be83349bf0b296bd63281ec25cdd55e97f7518c9df9f8a9.
- Michael Sember: Director, Compensation. Claim: alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:8. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9b21d6bc5d23b6d88be83349bf0b296bd63281ec25cdd55e97f7518c9df9f8a9.
- Natalie Leong: Director, Audit; Nominating and Governance · Chair. Claim: alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:9. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9b21d6bc5d23b6d88be83349bf0b296bd63281ec25cdd55e97f7518c9df9f8a9.
- Denise Carter: Chief Operating Officer and Director. Claim: alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:10. Valid from: 2026-03-26. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1cacf7a36f0c2e4250409be1b2f3cb2ad2ea7e91e269f0e61add98a0a0522895.
- Sally Lawlor: Chief Financial Officer. Claim: alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:11. Valid from: 2026-03-26. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ad75257c1f437c2f35b4430bd888e34395fec5a3192d9c22aad219eb174aa59f.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- Audit: Chair James Culverwell; Members James Culverwell (Chair); Joseph Cooper; Natalie Leong. Claim: alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:committee_record:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0293d22b8593ee48b3c8525fcca1ab9417afe30cdb8902e4544832ff707981f6.
- Compensation: Chair Dr. Dennis H. Langer; Members Dr. Dennis H. Langer (Chair); James Culverwell; Michael Sember. Claim: alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:committee_record:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0293d22b8593ee48b3c8525fcca1ab9417afe30cdb8902e4544832ff707981f6.
- Nominating and Governance: Chair Natalie Leong; Members Natalie Leong (Chair); Joseph Cooper. Claim: alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0293d22b8593ee48b3c8525fcca1ab9417afe30cdb8902e4544832ff707981f6.

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Quoin Pharmaceuticals, Ltd.. Claim: alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d8c9b76204f39985145903153dd7c498cc92b619b8f4fbe2a2cf9ae3455ba800.

## Entity Status

- Public listing published. Claim: alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d8c9b76204f39985145903153dd7c498cc92b619b8f4fbe2a2cf9ae3455ba800.

## Published Fact

- US. Claim: alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d8c9b76204f39985145903153dd7c498cc92b619b8f4fbe2a2cf9ae3455ba800.

## Committee Appointment

- James Culverwell: chair, Audit. Claim: alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:committee_appointment:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0293d22b8593ee48b3c8525fcca1ab9417afe30cdb8902e4544832ff707981f6.
- Joseph Cooper: member, Audit. Claim: alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:committee_appointment:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0293d22b8593ee48b3c8525fcca1ab9417afe30cdb8902e4544832ff707981f6.
- Natalie Leong: member, Audit. Claim: alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0293d22b8593ee48b3c8525fcca1ab9417afe30cdb8902e4544832ff707981f6.
- Dr. Dennis H. Langer: chair, Compensation. Claim: alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0293d22b8593ee48b3c8525fcca1ab9417afe30cdb8902e4544832ff707981f6.
- James Culverwell: member, Compensation. Claim: alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0293d22b8593ee48b3c8525fcca1ab9417afe30cdb8902e4544832ff707981f6.
- Michael Sember: member, Compensation. Claim: alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0293d22b8593ee48b3c8525fcca1ab9417afe30cdb8902e4544832ff707981f6.
- Natalie Leong: chair, Nominating and Governance. Claim: alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0293d22b8593ee48b3c8525fcca1ab9417afe30cdb8902e4544832ff707981f6.
- Joseph Cooper: member, Nominating and Governance. Claim: alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0293d22b8593ee48b3c8525fcca1ab9417afe30cdb8902e4544832ff707981f6.

## Security Listing

- QNRX (NASDAQ). Claim: alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:security_listing:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d8c9b76204f39985145903153dd7c498cc92b619b8f4fbe2a2cf9ae3455ba800.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:d8c9b76204f39985145903153dd7c498cc92b619b8f4fbe2a2cf9ae3455ba800: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/quoin-pharmaceuticals-ltd).
- alpha:projection-evidence:document:9b21d6bc5d23b6d88be83349bf0b296bd63281ec25cdd55e97f7518c9df9f8a9: [Quoin Pharmaceuticals, Ltd. DEF 14A 2025-07-17](https://www.sec.gov/Archives/edgar/data/1671502/000110465925068650/tm252555-3_def14a.htm).
- alpha:projection-evidence:document:1cacf7a36f0c2e4250409be1b2f3cb2ad2ea7e91e269f0e61add98a0a0522895: [QNRX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1671502/000110465926035251/qnrx-20251231x10k.htm).
- alpha:projection-evidence:document:ad75257c1f437c2f35b4430bd888e34395fec5a3192d9c22aad219eb174aa59f: [QNRX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1671502/000110465926035251/qnrx-20251231x10k.htm).
- alpha:projection-evidence:0293d22b8593ee48b3c8525fcca1ab9417afe30cdb8902e4544832ff707981f6: [Audit](https://www.sec.gov/Archives/edgar/data/1671502/000110465925068650/tm252555-3_def14a.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/quoin-pharmaceuticals-ltd)
- [Public Markdown](https://registry.alpha.ac/companies/quoin-pharmaceuticals-ltd.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/quoin-pharmaceuticals-ltd?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/quoin-pharmaceuticals-ltd?format=jsonld)
- MCP resource: `alpha://companies/quoin-pharmaceuticals-ltd` at https://mcp.alpha.ac/mcp


## Connected governance records

Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.

## Critical-risk oversight

Snapshot as of 2026-10-21T22:35:49.2461+00:00; recorded 2026-10-21T22:35:49.2461+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.